한방안이비인후피부과학회지 (The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology)

  • 제29권4호
  • /
  • Pages.142-155
  • /
  • 2016
  • /
  • 1738-6640(pISSN)
  • /
  • 2234-4020(eISSN)
대한한방안이비인후피부과학회 (The Society of Korean Medicine Ophthalmology, Otolaryngology & Dermatology)
권호 표지
DOI QR코드

DOI QR Code

영유아 아토피피부염 환자의 스테로이드 외용제 사용유무에 따른 한의학적 치료효과에 대한 후향적 연구

Retrospective Study of the Effectiveness of Korean Medical Treatment on Infant and Young Child Atopic Dermatitis Patients with or without Topical Co-administration of Steroid

  • 투고 : 2016.10.10
  • 심사 : 2016.11.17
  • 발행 : 2016.11.25
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: The purpose of this study is to examine whether there is a significant efficacy difference on infant and young child atopic dermatitis patients treated with Korean Medicine Treatment through 6 months between topical steroid used group and non-steroid group. Methods: The degree of atopic dermatitis was measured by the Objective SCORAD Index (OSI) with photographs of patients. Detailed analysis of the OSI score was compared based on the use of topical steroid. Results: 1. There was not a significant difference between the topical steroid group and the non-steroid group in regards of gender, age and initial OSI score. 2. The non-steroid group's OSI score decreased significantly from 50.17 to 29.20. 3. The topical steroid group's OSI score decreased significantly from 54.21 to 34.95. 76.19% of the patients in the topical steroid group discontinued steroid use within the 6-month period. The average time of discontinuation since the beginning of treatment was 3.36 months. 4. The OSI Improvement rate comparison of topical steroid group with non-steroid group did not show a significant difference over a 3-month and 6-month period. 5. Distribution of severe cases decreased in Both topical steroid and non-steroid group after 6 month treatment. Conclusions: The OSI score of infant and young child atopic dermatitis patients in both topical steroid and non-steroid group was decreased significantly with Korean medicine treatment through 6 months. There was no significant difference between topical steroid group and non-steroid group in OSI improvements over a 3-month period and 6-month period.

키워드

참고문헌

  1. Pyun BY. Relationship between Atopic Dermatitis, Wheezing during Infancy and Asthma Development. J Korean Med Assoc. 2007;50(6):533-8. https://doi.org/10.5124/jkma.2007.50.6.533
  2. The Korean Academy of Family Medicine. Textbook Of Family Medicine(The second volume). 2nd ed. Seoul:Hankookbook Publishing, Inc. 2010:1265-7.
  3. Yoo IY, Kim DH. Parenting Stress and Needs of Mothers of Children with Atopic Dermatitis. J Korean Acad Child Health Nurs. 2004;10(4):423-30.
  4. Park SJ, Lee JS, Ahn KM, Chung SJ. The Comparison of Growth and Nutrient Intakes in Children with and without Atopic Dermatitis. Korean J Community Nutr. 2012;17(3):271-9. https://doi.org/10.5720/kjcn.2012.17.3.271
  5. Kim HS, Cho SH. Treatment for atopic dermatitis. J Korean Med Assoc. 2014;57(3):226-33. https://doi.org/10.5124/jkma.2014.57.3.226
  6. Kalavala M, Dohil MA. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence. Am J Clin Dermatol. 2011;12(1):15-24. https://doi.org/10.2165/11319300-000000000-00000
  7. Cho SH. Atopic dermatitis in Korean. J Korean Med Assoc. 2014;57(3):205-7. https://doi.org/10.5124/jkma.2014.57.3.205
  8. Son CG. Pattern of Treatment Choice for Atopic Dermatitis by Child's Parents. J Korean Orient Med Ophtahlmol Otolaryngol Dermatol. 2014;27(1):37-44. https://doi.org/10.6114/jkood.2014.27.1.037
  9. Jo MS, Han JK, Kim YH. The Use of Oriental Medicine for Pediatric Outpatients with Atopic Dermatitis. J Pediatr Korean Med. 2011;25(2):8-14. https://doi.org/10.7778/jpkm.2011.25.2.008
  10. Park YL, Kim HD, Kim KH, Kim MN, Kim JW, Ro YS, et al. Report from ADRG: A study on the diagnostic criteria of Korean Atopic dermatitis. Korea J Dermatol. 2006;44(6):659-63.
  11. Kim JE, Kim HJ, Lew BL, Lee KH, Hong SP, Jang YH, et al. Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (PartI): General Management and Topical Treatment. Ann Dermatol. 2015;27(5):563-77. https://doi.org/10.5021/ad.2015.27.5.563
  12. European Task Force on Atopic Dermatitis. Severity Scoring of Atopic Dermatitis: The SCORAD Index, consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186(1):23-31. https://doi.org/10.1159/000247298
  13. Lee DH, Doh EJ, Lee JY, Park Y, Oh JW, Lee MH, et al. Multicenter questionnaires on the current management of atopic dermatitis in Korea. Allergy Asthma Respir Dis. 2016;4(4):271-5. https://doi.org/10.4168/aard.2016.4.4.271
  14. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol. 2006;118(1):152-69. https://doi.org/10.1016/j.jaci.2006.03.045
  15. Krakowski AC, Eichenfield LF, Dohil MA. Management of atopic dermatitis in the pediatric population. Pediatrics. 2008;122(4):812-24. https://doi.org/10.1542/peds.2007-2232
  16. Nicol NH, Boguniewicz M. Successful strategies in atopic dermatitis management. Dermatol Nurs. 2008;Suppl:3-18.
  17. Reitamo S, Remitz A. An update on current pharmacotherapy options in atopic dermatitis. Expert Opin Pharmacother. 2014;15(11):1517-24. https://doi.org/10.1517/14656566.2014.915941
  18. Darsow U, Wollenberg A, Simon D, Taieb A, Werfel T, Oranje A, et al. Difficult to control atopic dermatitis. World Allergy Organ J. 2013;6(1):6. https://doi.org/10.1186/1939-4551-6-6
  19. Furue M, Chiba T, Takeuchi S. Current status of atopic dermatitis in Japan. Asia Pac Allergy. 2011;1(2):64-72. https://doi.org/10.5415/apallergy.2011.1.2.64
  20. Kojima R, Fujiwara T, Matsuda A, Narita M, Matsubara O, Nonoyama S, et al. Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr Dermatol. 2013;30(1):29-35. https://doi.org/10.1111/j.1525-1470.2012.01808.x
  21. Seo MS, Kim KH. The study on atopic dermatitis papers published in the journal of korean oriental ophthalmology & otolaryngology & dermatology. J Korean Orient Med Ophtahlmol Otolaryngol Dermatol. 2009;22(3):108-21.
  22. Kim SY, Lee SD, Kim HO, Park YM. A Survey of the Awareness, Knowledge, and Behavior of Topical Steroid Use in Dermatologic Outpatients of the University Hospital. Korean Journal of Dermatology. 2008;46(4):473-9.
  23. Aschoff R, Schmitt J, Knuschke P, Koch E, Brautigam M, Meurer M. Evaluation of the atrophogenic potential of hydrocortisone 1% cream and pimecrolimus 1% cream in uninvolved forehead skin patients with atopic dermatitis using optical coherence tomography. Exp Dermatol. 2011;20(10):832-6. https://doi.org/10.1111/j.1600-0625.2011.01335.x
  24. Rapaport MJ, Lebwohl M. Corticosteroid addiction and withdrawal in the atopic: the red burning skin syndrome. Clin Dermatol. 2003;21(3):201-14. https://doi.org/10.1016/S0738-081X(02)00365-6
  25. Ben-Gashir MA, Seed PT, Hay RJ. Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol. 2004;150(2):284-90. https://doi.org/10.1111/j.1365-2133.2004.05776.x
  26. Gupta MA, Gupta AK, Schork NJ, Ellis CN. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med. 1994;56(1):36-40. https://doi.org/10.1097/00006842-199401000-00005
  27. Kim DH, Kang KH, Kim KW, Yoo IY. Management of children with atopic dermatitis. Pediatr Allergy Respir Dis (Korea). 2008;18(2):148-57.
  28. Park G. The revolution of atopy(2nd vol). Suwon:Freehug Publisher. 2011:19-22.
  29. Park HS, Kim YB. Five Cases of Atopic Dermatitis. J Korean Orient Med Ophtahlmol Otolaryngol Dermatol. 2003;16(2):255-60.
  30. Jung JY, Kim YB. Three Cases of Atopic Dermatitis. J Korean Orient Med Ophtahlmol Otolaryngol Dermatol. 2004;17(2):131-9.
  31. Song HJ, Han JK, Kim YH. A Clinical Study on the Treatment of Atopic Dermatitis by Using Kami-chungsimyeunjatang. J Pediatr Korean Med. 2007;21(3):21-31.